Numerous studies have demonstrated that GHK accelerates wound healing and tissue regeneration, increases collagen contraction, and triggers the secretion of factors that promote mesenchymal cell activation [10-13]
Poor exercise recovery and injury prone
Decreased aging, improved performance that are attributable to improved blood pressure control, improved glycemic control, weight loss, increased renal blood flow, restoration of normal glomerular hemodynamics, enhanced autoregulation, and prevention of oxidative injury are potential contributors to reducing cardiovascular events through the kidney-cardiovascular axis [85]
What can we do
[11] Who Should Not Use This Stack Several populations should avoid Ipamorelin entirely or use it only under close specialist supervision: Active or prior history of any GH-sensitive malignancy (e.g., pituitary adenoma, prostate cancer, colorectal cancer) Diabetic patients with poor glycemic control (HbA1c above 8%) Pregnancy or breastfeeding (no safety data) Pediatric patients with open epiphyses (risk of disproportionate bone growth) Wilson's disease or other copper metabolism disorders (GHK-Cu contraindicated) The FDA has not approved Ipamorelin or GHK-Cu for any human therapeutic indication
